Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017295 |
---|---|
Receipt number | R000020065 |
Scientific Title | An exploratory trial of betaine supplementation in patients with schizophrenia |
Date of disclosure of the study information | 2015/06/01 |
Last modified on | 2020/10/29 12:32:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/04/27 15:53:23 | ||
2 | Update | 2015/05/14 17:50:19 | Organization Organization Category of Funding Organization |
|
3 | Update | 2015/10/27 12:51:43 | Anticipated trial start date |
|
4 | Update | 2016/03/11 11:28:04 | Recruitment status |
|
5 | Update | 2016/05/27 10:35:49 | Anticipated trial start date |
|
6 | Update | 2016/10/26 14:38:06 | Name of primary person or sponsor Organization Category of Funding Organization |
|
7 | Update | 2016/10/26 14:38:43 | Anticipated trial start date |
|
8 | Update | 2017/04/27 10:54:02 | Anticipated trial start date |
|
9 | Update | 2017/08/25 11:27:21 | Recruitment status |
|
10 | Update | 2018/04/13 19:18:55 | Target sample size |
|
11 | Update | 2019/05/07 20:21:53 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization1 Tel1 Email1 Organization Organization Address Address Tel |
|
12 | Update | 2019/05/07 20:25:33 | Date of IRB Last follow-up date |
|
13 | Update | 2019/08/28 19:56:35 | Gender Target sample size |
|
14 | Update | 2019/08/28 19:58:51 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
15 | Update | 2020/07/13 17:36:08 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator |
|
16 | Update | 2020/07/13 17:37:27 | Recruitment status Last follow-up date |
|
17 | Update | 2020/07/13 17:38:03 | Number of participants that the trial has enrolled |
|
18 | Update | 2020/10/29 12:32:53 | Key secondary outcomes Key secondary outcomes |